Drugplain

Miglustat 100 mg/1

miglustat · CAPSULE · CoTherix, Inc.

No Recall History
Plain English

Miglustat is a capsule containing miglustat at 100 mg/1, taken oral. Manufactured by CoTherix, Inc..

Key Facts

Brand Name
Miglustat
Generic Name
miglustat
NDC Code (Product)
10148-201
Manufacturer
CoTherix, Inc.
Strength
100 mg/1
Dosage Form
CAPSULE
Route
ORAL
Marketing Status
Application #
NDA021348
Drug Class
Glucosylceramide Synthase Inhibitor [EPC]; Enzyme Stabilizer [EPC]
Marketing Start
04/25/2018

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

seizure20 reports
diarrhoea19 reports
pneumonia18 reports
pyrexia10 reports
vomiting10 reports
pneumonia aspiration9 reports
dysphagia8 reports
respiratory failure8 reports
condition aggravated7 reports
cough7 reports

Frequently Asked Questions

What is Miglustat used for?

Miglustat contains miglustat. It is a capsule taken oral. Consult your doctor for specific uses.

Is Miglustat a controlled substance?

Miglustat is not classified as a controlled substance by the DEA.

What is the generic name for Miglustat?

The generic name for Miglustat is miglustat. There are 4 other brand versions of miglustat.

What is the NDC code for Miglustat 100 mg/1?

The NDC (National Drug Code) for Miglustat 100 mg/1 is 10148-201, listed by CoTherix, Inc..

Product NDC

10148-201

Package NDC

10148-201-90

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)